Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation

被引:0
|
作者
Y Suzuki
R Sato
M Sato
S Endo
机构
[1] Iwate Medical University,
来源
Critical Care | / 17卷 / Suppl 2期
关键词
Platelet Count; Thrombin; Hospital Mortality; Antithrombin; Disseminate Intravascular Coagulation;
D O I
10.1186/cc11997
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Evaluation of recombinant thrombomodulin treatment for septic disseminated intravascular coagulation
    Yamauchi, Hiroki
    Miura, Masanao
    Nakamura, Fujio
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [22] Erratum to: Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation
    Akira Shirahata
    Jun Mimuro
    Hoyu Takahashi
    Isao Kitajima
    Hajime Tsuji
    Yutaka Eguchi
    Tadashi Matsushita
    Masahiro Kajiki
    Goichi Honda
    Yoichi Sakata
    European Journal of Pediatrics, 2014, 173 : 1405 - 1406
  • [23] RANDOMIZED CONTROLLED TRIAL OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN FOR SEPSIS AND DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS
    Ushizawa, Hiroto
    Isotani, Eiji
    Otomo, Yasuhiro
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U121 - U121
  • [24] Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction
    Hayakawa, Mineji
    Kushimoto, Shigeki
    Watanabe, Eizo
    Goto, Koji
    Suzuki, Yasushi
    Kotani, Toru
    Kiguchi, Takeyuki
    Yatabe, Tomoaki
    Tagawa, Jun
    Komatsu, Fumiyo
    Gando, Satoshi
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (05) : 851 - 859
  • [25] Treatment effects of recombinant human soluble thrombomodulin in patients with septic urinary tract infection-induced disseminated intravascular coagulation
    Hashimoto, Y.
    Tozawa, K.
    Kohri, K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 219 - 219
  • [26] TREATMENT EFFECTS OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN IN PATIENTS WITH SEPTIC URINARY TRACT INFECTION-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
    Hashimoto, Yoshihiro
    Kawai, Noriyasu
    Tozawa, Keiichi
    Kohri, Kenjiro
    JOURNAL OF UROLOGY, 2013, 189 (04): : E473 - E473
  • [27] Efficacy and safety of recombinant human soluble thrombomodulin in septic antithrombin substitution-resistant disseminated intravascular coagulation: results of a pilot study
    Eguchi, Y.
    Saotome, T.
    Matsumura, K.
    Tsujita, Y.
    Hamamoto, T.
    Fujino, K.
    Hayafuji, K.
    Fuse, I
    Furukawa, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1164 - 1165
  • [28] Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors
    Kashiwagi, Shinichiro
    Asano, Yuka
    Takahashi, Katsuyuki
    Shibutani, Masatsune
    Amano, Ryosuke
    Tomita, Shuhei
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2019, 39 (05) : 2259 - 2264
  • [29] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN, THROMBOMODULIN-α, IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WITH SEVERE RENAL IMPAIRMENT
    Hayakawa, M.
    Honma, T.
    Yamamoto, H.
    Mukai, N.
    Sugano, M.
    Kubota, N.
    Uegaki, S.
    Sawamura, A.
    Gando, S.
    INTENSIVE CARE MEDICINE, 2011, 37 : S41 - S41
  • [30] The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm
    Hoshina, Katsuyuki
    Shigematsu, Kunihiro
    Hosaka, Akihiro
    Okamoto, Hiroyuki
    Miyata, Tetsuro
    Watanabe, Toshiaki
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (04) : 389 - 391